Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 115 | 104 | 176 | 314 | 429 |
| Cost of Goods | 65 | 54 | 131 | 431 | 181 |
| Gross Profit | 50 | 50 | 45 | -117 | 248 |
| Operating Expenses | 13,630 | 4,736 | 9,443 | 16,493 | 6,942 |
| Operating Income | -13,515 | -4,632 | -9,267 | -16,179 | -6,513 |
| Interest Expense | 31 | 8 | 15 | 13 | 14 |
| Other Income | 53 | 110 | 153 | 200 | 38 |
| Pre-tax Income | -13,493 | -4,530 | -9,129 | -15,992 | -6,489 |
| Net Income Continuous | -13,493 | -4,530 | -9,129 | -15,992 | -6,489 |
| Net Income | $-13,493 | $-4,530 | $-9,129 | $-15,992 | $-6,489 |
| EPS Basic Total Ops | -0.98 | -0.36 | -1.13 | -2.27 | -0.81 |
| EPS Basic Continuous Ops | -0.98 | -0.35 | -1.10 | -2.31 | -0.81 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.04 | N/A |
| EPS Diluted Total Ops | -0.98 | -0.36 | -1.13 | -2.27 | -0.81 |
| EPS Diluted Continuous Ops | -0.98 | -0.35 | -1.10 | -2.31 | -0.81 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.04 | N/A |
| EPS Diluted Before Non-Recurring Items | -0.98 | -0.36 | -1.13 | N/A | N/A |
| EBITDA(a) | $-13,175 | $-4,306 | $-8,932 | $-15,854 | $-6,087 |